A very positive outcome from the CSL112 trial PLUS a reduction in interest rates late next year might get CSL to $400. To be safe I wouldn't bet on much more than earnings growth equivalent movement in the share price. So, from here maybe circa $300 to $350 late next year which is roughly 30 to 35 times FY24 consensus. $400 a share are we're back to PEs at 40 which seems a stretch with rates still possible 3%+ late next year, so obviously will need some blockbuster CSL112 projections built into the price to get there.
Ann: CSL Notice of Research & Development Investor Briefing, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.00 |
Change
2.260(0.78%) |
Mkt cap ! $141.5B | |||
| Open | High | Low | Value | Volume |
| $294.00 | $294.75 | $290.82 | $491.6M | 1.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8192 | $292.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.06 | 12368 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |